Merck Tbk (MERK)
PT Merck Tbk
Rp 3.610
0,00(0,00%)
CLOSED- Harga Pasar: Rp 3.610
- Volume Perdagangan: Rp 34.900
- Kapitalisasi Pasar: Rp 1.617.279.975.424
- Mata Uang: IDR
- Pasar: id_market
- Dividend Yield: 8,79%
- Dividend Rate: Rp 320
- Price to Book: 1,97
- Forward P/E: -
- Trailing P/E: 11,31
- EPS Tahun Ini: Rp 319,12
- EPS Perkiraan: Rp -
- Bid: Rp 3.610,00
- Ask: Rp 3.620,00
- Bid Size: 0,00
- Ask Size: 0,00
- Volume Rata-rata 10 Hari: 19.712
- Volume Rata-rata 3 Bulan: 13.412
- Book Value: Rp 1.831,40
- Fifty Day Average: Rp 3.546,80
- Two Hundred Day Average: Rp 3.552,40
- 52 Week Range: 3080.0 - 4400.0
- 52 Week High: Rp 4.400,00
- 52 Week Low: Rp 3.080,00
- Regular Market Open: Rp 3.600,00
- Regular Market Previous Close: Rp 3.610,00
- Regular Market Day High: Rp 3.650,00
- Regular Market Day Low: Rp 3.600,00
- Earnings Call Start: -
- Earnings Call End: -
- Earnings Timestamp: -
Sektor
Healthcare
Industri
Drug Manufacturers - Specialty & Generic
Alamat Perusahaan
Jl. TB Simatupang No. 8
Pasar Rebo
Jakarta Timur
13760
Ringkasan Bisnis
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders, such as hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is based in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.